Although specific individual subunits of eIF3 have been revealed to be up-regulated or down-regulated in numerous human tumors [19, 20, 22, 27–29], our study further reveals the expression profile and clinical implications of eIF3 subunits in gliomas. Here, EIF3A is linked to central nervous system cancer.